Literature DB >> 22238459

Plac8-dependent and inducible NO synthase-dependent mechanisms clear Chlamydia muridarum infections from the genital tract.

Raymond M Johnson1, Micah S Kerr, James E Slaven.   

Abstract

Chlamydia trachomatis urogenital serovars replicate predominantly in genital tract epithelium. This tissue tropism poses a unique challenge for host defense and vaccine development. Studies utilizing the Chlamydia muridarum mouse model have shown that CD4 T cells are critical for clearing genital tract infections. In vitro studies have shown that CD4 T cells terminate infection by upregulating epithelial inducible NO synthase (iNOS) transcription and NO production. However, this mechanism is not critical, as iNOS-deficient mice clear infections normally. We recently showed that a subset of Chlamydia-specific CD4 T cell clones could terminate replication in epithelial cells using an iNOS-independent mechanism requiring T cell degranulation. We advance that work using microarrays to compare iNOS-dependent and iNOS-independent CD4 T cell clones. Plac8 was differentially expressed by clones having the iNOS-independent mechanism. Plac8-deficient mice had delayed clearance of infection, and Plac8-deficient mice treated with the iNOS inhibitor N-monomethyl-l-arginine were largely unable to resolve genital tract infections over 8 wk. These results demonstrate that there are two independent and redundant T cell mechanisms for clearing C. muridarum genital tract infections: one dependent on iNOS, and the other dependent on Plac8. Although T cell subsets are routinely defined by cytokine profiles, there may be important subdivisions by effector function, in this case CD4(Plac8).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22238459      PMCID: PMC3303601          DOI: 10.4049/jimmunol.1102764

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

1.  Differential sensitivity of distinct Chlamydia trachomatis isolates to IFN-gamma-mediated inhibition.

Authors:  L L Perry; H Su; K Feilzer; R Messer; S Hughes; W Whitmire; H D Caldwell
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

2.  Onzin, a c-Myc-repressed target, promotes survival and transformation by modulating the Akt-Mdm2-p53 pathway.

Authors:  Kenneth Rogulski; Youjun Li; Kristi Rothermund; Lixia Pu; Simon Watkins; Fenghua Yi; Edward V Prochownik
Journal:  Oncogene       Date:  2005-11-17       Impact factor: 9.867

3.  Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice.

Authors:  H Su; K Feilzer; H D Caldwell; R P Morrison
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

4.  Inducible nitric oxide synthase does not affect resolution of murine chlamydial genital tract infections or eradication of chlamydiae in primary murine cell culture.

Authors:  K H Ramsey; G S Miranpuri; C E Poulsen; N B Marthakis; L M Braune; G I Byrne
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

5.  The effect of doxycycline treatment on the development of protective immunity in a murine model of chlamydial genital infection.

Authors:  H Su; R Morrison; R Messer; W Whitmire; S Hughes; H D Caldwell
Journal:  J Infect Dis       Date:  1999-10       Impact factor: 5.226

6.  Chlamydial IFN-gamma immune evasion is linked to host infection tropism.

Authors:  David E Nelson; Dezso P Virok; Heidi Wood; Christine Roshick; Raymond M Johnson; William M Whitmire; Deborah D Crane; Olivia Steele-Mortimer; Laszlo Kari; Grant McClarty; Harlan D Caldwell
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-14       Impact factor: 11.205

7.  Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways.

Authors:  L L Perry; K Feilzer; H D Caldwell
Journal:  J Immunol       Date:  1997-04-01       Impact factor: 5.422

8.  Clearance of Chlamydia trachomatis from the murine genital mucosa does not require perforin-mediated cytolysis or Fas-mediated apoptosis.

Authors:  L L Perry; K Feilzer; S Hughes; H D Caldwell
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

9.  The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection.

Authors:  Robert C Brunham; Babak Pourbohloul; Sunny Mak; Rick White; Michael L Rekart
Journal:  J Infect Dis       Date:  2005-10-10       Impact factor: 5.226

10.  Chlamydial infection in inducible nitric oxide synthase knockout mice.

Authors:  J U Igietseme; L L Perry; G A Ananaba; I M Uriri; O O Ojior; S N Kumar; H D Caldwell
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

View more
  34 in total

1.  Differentially expressed genes in PPARγ-deficient MSCs.

Authors:  Yun Su; Xiaona Shen; Jie Chen; Carlos M Isales; Jing Zhao; Xing-Ming Shi
Journal:  Mol Cell Endocrinol       Date:  2017-07-31       Impact factor: 4.102

2.  Identification of stage-specific genes associated with lupus nephritis and response to remission induction in (NZB × NZW)F1 and NZM2410 mice.

Authors:  Ramalingam Bethunaickan; Celine C Berthier; Weijia Zhang; Ridvan Eksi; Hong-Dong Li; Yuanfang Guan; Matthias Kretzler; Anne Davidson
Journal:  Arthritis Rheumatol       Date:  2014-08       Impact factor: 10.995

3.  Reply to Vicetti Miguel et al., "Setting Sights on Chlamydia Immunity's Central Paradigm: Can We Hit a Moving Target?"

Authors:  Raymond M Johnson; Robert C Brunham
Journal:  Infect Immun       Date:  2017-06-20       Impact factor: 3.441

4.  Modeling the transcriptome of genital tract epithelial cells and macrophages in healthy mucosa versus mucosa inflamed by Chlamydia muridarum infection.

Authors:  Raymond M Johnson; Micah S Kerr
Journal:  Pathog Dis       Date:  2015-10-29       Impact factor: 3.166

5.  Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.

Authors:  Liping Shi; Long Xiao; Baoli Heng; Shijie Mo; Weijun Chen; Zexuan Su
Journal:  Int Urol Nephrol       Date:  2017-03-27       Impact factor: 2.370

Review 6.  Tissue-Resident T Cells as the Central Paradigm of Chlamydia Immunity.

Authors:  Raymond M Johnson; Robert C Brunham
Journal:  Infect Immun       Date:  2016-03-24       Impact factor: 3.441

7.  Evaluation of a multisubunit recombinant polymorphic membrane protein and major outer membrane protein T cell vaccine against Chlamydia muridarum genital infection in three strains of mice.

Authors:  Hong Yu; Karuna P Karunakaran; Xiaozhou Jiang; Robert C Brunham
Journal:  Vaccine       Date:  2014-06-30       Impact factor: 3.641

8.  A Chlamydia-Specific TCR-Transgenic Mouse Demonstrates Th1 Polyfunctionality with Enhanced Effector Function.

Authors:  Taylor B Poston; Yanyan Qu; Jenna Girardi; Catherine M O'Connell; Lauren C Frazer; Ali N Russell; McKensie Wall; Uma M Nagarajan; Toni Darville
Journal:  J Immunol       Date:  2017-08-30       Impact factor: 5.422

Review 9.  Chlamydia trachomatis control requires a vaccine.

Authors:  Robert C Brunham; Rino Rappuoli
Journal:  Vaccine       Date:  2013-01-29       Impact factor: 3.641

10.  An atypical CD8 T-cell response to Chlamydia muridarum genital tract infections includes T cells that produce interleukin-13.

Authors:  Raymond M Johnson; Micah S Kerr; James E Slaven
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.